Formulating for the Future: Tackling the Challenges of High-Concentration Protein Therapeutics with Dr. Jeremy Guo
We recently sat down with Dr. Jeremy Guo, Ph.D., SVP, Head of Drug Product Development & Clinical DP Network, WuXi Biologics, to discuss both the challenges and innovations associated with developing high-concentration protein formulations. High-concentration formulations, which typically exceed 100 mg/mL, are essential for subcutaneous or intramuscular administration, shorter treatment times, and patient convenience, especially … Continued